Setting Reference Pricing on Medicines
The MPs discussed draft changes to the Law of Georgia on Medicines and Pharmaceutical Activities at the plenary session with the 1st reading.
The draft package was presented by the First Deputy Minister of Internally Displaced Persons from the Occupied Territories, Labor, Health and Social Affairs of Georgia, Tamar Gabunia.
The draft law envisages setting reference prices on medicines from 2023. According to the changes, State will set the maximum ceiling for the prices and selling of the medicines at the price exceeding reference point will be prohibited. The obligations of the State Regulation Agency for Medical and Pharmaceutical Activities to supervise prices is determined.
The package defines measures of administrative responsibility for selling medicines at the price exceeding reference price.
At the first stage, reference prices will be set for medicines for treatment of chronic diseases and oncologic diseases; gradually reference prices will be set for medicines of other groups.
The novelties are aimed at increased accessibility to medicines and ensuring fair prices and competitive pharmaceutical market.
The Ministry of Health works on elaboration of reference pricing mechanism jointly with local and international experts.
